Table 4. CTC grades 3 to 5 toxicities .... | American Society of Hematology

Table 4.

CTC grades 3 to 5 toxicities

	Cumulative incidences					Mean number of events per patient
Category	Nonablative patients, %	Ablative patients, %	P	Nonablative patients	Ablative patients	P
Hematologic				2.3	4.7	< 10^-4
Neutropenia	58	100	< 10^-4	—	—	—
Thrombopenia	18	97	< 10^-4	—	—	—
Rejection	7	0	.008	—	—	—
Cardiovascular	58	66	.31	0.7	0.8	.28
Gastrointestinal	8	78	< 10^-4	0.1	0.9	< 10^-4
Hemorrhage	1	8	.04	0.01	0.1	.05
Hepatic	16	49	< 10^-4	0.2	1.0	< 10^-4
Infection	58	88	< 10^-4	0.9	2.4	< 10^-4
Metabolic	58	74	.04	1.1	1.7	.01
Neurologic	7	15	.11	0.1	0.2	.09
Pulmonary	4	14	.04	0.04	0.2	.03
Renal	12	18	.35	0.2	0.3	.41
Other	12^*	18†	.35	0.1	0.3	.08

	Cumulative incidences					Mean number of events per patient
Category	Nonablative patients, %	Ablative patients, %	P	Nonablative patients	Ablative patients	P
Hematologic				2.3	4.7	< 10^-4
Neutropenia	58	100	< 10^-4	—	—	—
Thrombopenia	18	97	< 10^-4	—	—	—
Rejection	7	0	.008	—	—	—
Cardiovascular	58	66	.31	0.7	0.8	.28
Gastrointestinal	8	78	< 10^-4	0.1	0.9	< 10^-4
Hemorrhage	1	8	.04	0.01	0.1	.05
Hepatic	16	49	< 10^-4	0.2	1.0	< 10^-4
Infection	58	88	< 10^-4	0.9	2.4	< 10^-4
Metabolic	58	74	.04	1.1	1.7	.01
Neurologic	7	15	.11	0.1	0.2	.09
Pulmonary	4	14	.04	0.04	0.2	.03
Renal	12	18	.35	0.2	0.3	.41
Other	12^*	18†	.35	0.1	0.3	.08

— indicates not done.

Hematopoietic cell infusion reactions (n = 5), musculoskeletal events (n = 2), hemolytic-uremic syndrome (HUS, n = 1), and allergic reaction (n = 1)

Dermatological (n = 4), musculoskeletal (n = 4), HUS (n = 3) and hematopoietic cell infusion reactions (n = 2)